Woo Ian Ying
Woo Ian Ying, DIR, reported a transaction classified as exercise at NovaBridge Biosciences involving 5770.000000 shares for an estimated $0.00. Reported holdings after the transaction were 11540.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 19, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
NBP price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0002115245-26-000004 Restricted Share Units
- Transaction date
- Oct 15, 2026 Filed Oct 19, 2026, 08:15 PM · 4d delay
- Shares
- 5,770 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 11,540 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
- F2
Reported securities are represented by 5,770 ADSs.
- F3
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.
- F4F6(2 footnotes)
Reported securities represent ADSs.
- F5
On October 15, 2025, the Reporting Person was granted 17,310 restricted share units ("RSUs"). The RSUs vest or shall vest over three years in equal annual installments on October 15, 2026, 2027 and 20…
0 other transactions
0 recent txs